Stockreport

Third Rock-backed Maze Therapeutics reveals profit in US IPO filing [Yahoo! Finance Canada]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Maze's decision follows a strong 2024 for biotech companies, with firms such as Septerna and Bicara Therapeutics receiving a positive response from investors at their d [Read more]